Recent studies have demonstrated that obestatin can restore to some extent muscle integrity and function in a Duchenne muscular dystrophy (DMD) murine model: obestatin‐treated mdx mice display skeletal muscle remodelling towards an oxidative phenotype, with improved muscle strength and reduced skeletal muscle pathology.15 This evidence concerns the gene GHRL and Duchenne muscular dystrophy.